We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+66.43%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$457M
AUM Growth
+$5.96M
(+1.3%)
Cap. Flow
-$79.4M
Cap. Flow
% of AUM
-17.39%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
114
New
24
Increased
11
Reduced
44
Closed
23
Top Buys
| 1 |
SPRB
Spruce Biosciences
SPRB
|
+$14.1M |
| 2 |
AstraZeneca
AZN
|
+$13.9M |
| 3 |
Sanofi
SNY
|
+$10.9M |
| 4 |
Universal Health Services
UHS
|
+$10.1M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
+$9.73M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$17M |
| 2 |
McKesson
MCK
|
+$11.8M |
| 3 |
Molina Healthcare
MOH
|
+$9.7M |
| 4 |
AMN Healthcare
AMN
|
+$9.23M |
| 5 |
Cardinal Health
CAH
|
+$8.68M |
Sector Composition
| 1 | Healthcare | 87.36% |
| 2 | Technology | 1.15% |
| 3 | Consumer Staples | 0.82% |
| 4 | Consumer Discretionary | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Curis
CRIS
$8.5M
| $39M | 8.53% |
11,891
-484
| -4% | -$581K |
|
2
SPDR Gold Trust
GLD
$131B
| $18.3M | 4% |
102,509
-25,693
| -20% | -$4.52M |
|
|
SPRB
3
Spruce Biosciences
SPRB
$129M
| $15.5M | 3.39% |
+8,489
| New | +$14.1M |
|
4
Coherus Oncology
CHRS
$225M
| $15M | 3.29% |
864,056
-180,105
| -17% | -$3.21M |
|
|
ALBO
5
DELISTED
Albireo Pharma Inc
ALBO
| $13.3M | 2.91% |
354,210
-124,414
| -26% | -$4.52M |
|
6
HCA Healthcare
HCA
$82B
| $13.3M | 2.91% |
80,745
-25,187
| -24% | -$3.68M |
|
|
7
AstraZeneca
AZN
$261B
| $13.1M | 2.88% |
+131,500
| New | +$13.9M |
|
8
Cigna
CI
$79.4B
| $13M | 2.84% |
62,265
-19,150
| -24% | -$3.76M |
|
9
Cencora
COR
$58.7B
| $12.5M | 2.74% |
127,781
-36,090
| -22% | -$3.61M |
|
|
WBA
10
DELISTED
Walgreens Boots Alliance
WBA
| $12.3M | 2.7% |
308,686
+8,592
| +3% | +$333K |
|
|
HRC
11
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $12.1M | 2.64% |
123,198
-76,702
| -38% | -$7.17M |
|
|
12
Universal Health Services
UHS
$8.81B
| $11.1M | 2.43% |
+80,843
| New | +$10.1M |
|
|
13
Sanofi
SNY
$104B
| $10.7M | 2.34% |
+220,201
| New | +$10.9M |
|
14
Amgen
AMGN
$193B
| $9.2M | 2.01% |
+40,000
| New | +$9.22M |
|
|
15
AMN Healthcare
AMN
$1.27B
| $8.91M | 1.95% |
130,598
-141,635
| -52% | -$9.23M |
|
16
BioMarin Pharmaceuticals
BMRN
$11.4B
| $8.84M | 1.94% |
100,844
-93,900
| -48% | -$7.44M |
|
|
17
Mirum Pharmaceuticals
MIRM
$7.25B
| $8.64M | 1.89% |
+494,743
| New | +$9.73M |
|
|
18
Cardinal Health
CAH
$53.4B
| $8.31M | 1.82% |
155,217
-167,263
| -52% | -$8.68M |
|
|
19
McKesson
MCK
$94.2B
| $8.26M | 1.81% |
47,462
-70,987
| -60% | -$11.8M |
|
|
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.24M | 1.58% |
98,901
-48,599
| -33% | -$3.61M |
|
21
Becton Dickinson
BDX
$42.3B
| $6.83M | 1.5% |
27,997
+11,010
| +65% | +$2.57M |
|
22
Teva Pharmaceuticals
TEVA
$36.9B
| $6.66M | 1.46% |
690,386
-261,305
| -27% | -$2.5M |
|
|
SOLY
23
DELISTED
Soliton, Inc.
SOLY
| $6.62M | 1.45% |
862,405
-162,595
| -16% | -$1.34M |
|
24
Vertex Pharmaceuticals
VRTX
$120B
| $6.19M | 1.36% |
+26,200
| New | +$6.01M |
|
25
Orthofix Medical
OFIX
$441M
| $5.95M | 1.3% |
138,525
-79,392
| -36% | -$2.9M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA